20 Years on Wall Street Taught Me: Big Dividend Healthcare Stocks Never Go Out of Style24/7 Wall Street • 03/18/26
Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trialReuters • 03/17/26
Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast CancerBusiness Wire • 03/17/26
Expect Pfizer To Comeback: Take The Dividend While Waiting For Capital AppreciationSeeking Alpha • 03/13/26
Pfizer (PFE) Sees a More Significant Dip Than Broader Market: Some Facts to KnowZacks Investment Research • 03/12/26
Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic DermatitisBusiness Wire • 03/09/26
Wall Street Breakfast Podcast: India To Buy Russian Oil As War Disrupts SuppliesSeeking Alpha • 03/06/26
Pfizer (PFE) Down 0.6% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/05/26
Can Pfizer Reignite Growth Amid COVID Declines and Patent Expirations?Zacks Investment Research • 03/05/26